wintrex 1000 mg/100 mg/12,2 mg pulveris iekšķīgi lietojama šķīduma pagatavošanai
us pharmacia sp. z o.o., poland - paracetamolum, skābes ascorbicum, phenylephrini hydrochloridum - pulveris iekšķīgi lietojama šķīduma pagatavošanai - 1000 mg/100 mg/12,2 mg
vilkābeļu šķidrais ekstrakts valentis pilieni iekšķīgai lietošanai, šķīdums
uab valentis, lithuania - vilkābeļcu augļcu šķidrais ekstrakts - pilieni iekšķīgai lietošanai, šķīdums
fosrenol 1000 mg pulveris iekšķīgai lietošanai
takeda pharmaceuticals international ag ireland branch, ireland - lantāns - pulveris iekšķīgai lietošanai - 1000 mg
biresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - zāles obstruktīvu elpceļu slimību, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
duoresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - zāles obstruktīvu elpceļu slimību, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
fosrenol 1000 mg košļājamās tabletes
takeda pharmaceuticals international ag ireland branch, ireland - lantāns - košļājamā tablete - 1000 mg
theraflu 1000 mg/12,2 mg/200 mg pulveris iekšķīgi lietojama šķīduma pagatavošanai
glaxosmithkline dungarvan ltd., ireland - paracetamolum, phenylephrini hydrochloridum, guaifenesinum - pulveris iekšķīgi lietojama šķīduma pagatavošanai - 1000 mg/12,2 mg/200 mg
acetylcysteine sandoz 100 mg putojošās tabletes
sandoz d.d., slovenia - acetilcisteīns - putojošā tablete - 100 mg
ketipinor 100 mg apvalkotās tabletes
orion corporation, finland - kvetiapīns - apvalkotā tablete - 100 mg
sumamed 100 mg/5 ml pulveris iekšķīgi lietojamas suspensijas pagatavošanai
teva pharma b.v., netherlands - azitromicīns - pulveris iekšķīgi lietojamas suspensijas pagatavošanai - 100 mg/5 ml